Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show

Treatment of lung cancer

Thematic Poster Session
Chairs: M. Zamboni (Rio De Janeiro, Brazil), V. Westeel (Besancon, France)
Co-morbidity and lung cancer surgery
T. Win, L. Sharples, A. J. Ritchie, F. C. Wells, C. M. Laroche (Cambridge, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Adjuvant chemotherapy and prophylactic cranial irradiation in the combined treatment for the operable patients with small cell lung cancer I-III stage
P. I. Moiseev (Minsk, Belarus)
Congress or journal article abstract
Congress or journal article abstract
Pneumonectomy for bronchogenic carcinoma: the predictors of early morbidity and mortality
G. Haciibrahimoglu, A. Y. Karamustafaoglu, L. Cansever, I. C. Kocatürk, M. A. Bedirhan (Istanbul, Turkey)
Congress or journal article abstract
Congress or journal article abstract
A retrospective study of one year surgical interventions in lung cancer at Ashford and St Peter‘s NHS Trust
P. V. Murray, E. A. Ginn, M. G. Britton, R. Sayer (Chertsey, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Death causes in patients operated for lung cancer
Z. M. Kosjerina, V. M. Kosjerina Ostric (Sremska Kamenica, Serbia And Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Adjuvant radiotherapy in resected non small cell lung cancer
S. S. Vucicevic, N. P. Jovanovic-Korda, B. J. Lukac, D. M. Mandaric, L. D. Radosevic-Jelic (Belgrade, Serbia And Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Cryotherapy as an adjuvant to radiotherapy in lung cancer
R. Jean-François, J. Agulnik, M. Gagnon, P. Del Vecchio (Montréal, Canada)
Congress or journal article abstract
Congress or journal article abstract
Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy
T. Rikimaru, J. Yonemitu, M. Nishiyama, A. Shimada, H. Aizawa (Chikushino, Kurume, Japan)
Congress or journal article abstract
Congress or journal article abstract
The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy
I. A. Dimitroulis, C. S. Pagratis, K. Tsikritsaki, S. Paboukos, G. M. Zarbis, M. G. Toumbis (Athens, Greece)
Congress or journal article abstract
Congress or journal article abstract
First line treatment with gemcitabine plus cisplatine in non-small cell lung cancer: a comparison with etoposide plus cisplatin
Y. Bulbul, F. Oztuna, T. Ozlu, N. E. Bulbul (Trabzon, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Docetaxel in combination with carboplatin in the treatment of Stage IIIb and IV non-small cell lung cancer patients. A Phase II study
K. P. Zarogoulidis, A. Xafenias, G. A. Balassoulis, T. N. Kontakiotis, E. Fachantidou, P. K. Zarogoulidis (Thessaloniki, Greece)
Congress or journal article abstract
Congress or journal article abstract
Cisplatin and docetaxel induction chemotherapy results
N. Erdal, F. Ece, N. Hatabay, S. Halezaroglu, A. Atasalihi, F. Aksoy (Istanbul, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Chemotherapy in advanced non small cell lung cancer
A. Hayouni, H. Njima, A. Abdelghani, S. Mezghani, A. Garrouche, N. Klabi, M. Benzarti, M. Jerray (Sousse, Tunisia)
Congress or journal article abstract
Congress or journal article abstract
Different efficacy between carboplatin (Cpl) and gemcitabine (Gem) on median survival time of elderly non small cell lung cancer (NSCLC) patients
E. Mylonaki, A. Kapetangiorgis, P. Stiropoulos, A. Ioannidou, T. Kontakiotis, P. Christaki (Exochi, Greece)
Congress or journal article abstract
Congress or journal article abstract
Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy
O. A. Sukhoversha (Dnipropetrovs‘k, Ukraine)
Congress or journal article abstract
Congress or journal article abstract
Effectivity of chemotherapy regimen included carboplatin, ifosfamide, etoposide with or without adding interferon alpha 2a in treatment of patients with small cell lung carcinoma
S. Erginel, M. Metintas, G. Ak, F. Alatas, E. Kurt, I. Ucgun, H. Yildirim, I. A. Ak (Eskisehir, Turkey)
Congress or journal article abstract
Congress or journal article abstract
Survival of patients with relapsing small cell lung cancer (SCLC) after new line chemotherapy administration
K. P. Zarogoulidis, G. A. Balassoulis, T. Tsiouda, D. S. Papakosta, T. N. Kontakiotis (Thessaloniki, Greece)
Congress or journal article abstract
Congress or journal article abstract
Pegylated liposomal doxorubicin HCl (Caelyx) in combination with sandostatin LAR as salvage therapy in patients with small cell lung cancer
K. N. Syrigos, E. Hatzidarellis, A. G. Charpidou, C. Alamara, K. Pantazopoulos, F. Skotti, D. Antoniou, N. Georgatou (Athens, Greece)
Congress or journal article abstract
Congress or journal article abstract
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
M. Petrovic, I. Tomic, S. Mojsilovic, I. Jevtovic (Kragujevac, Belgrade, Serbia And Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Relation between ERCC1 expression in sputum and survival after cisplatin-based chemotherapy in non-small cell lung cancer
M. H. Jung, H. K. Kim, C. H. Oak, T. W. Jang, C. H. Jeon (Busan, Daegu, Republic Of Korea)
Congress or journal article abstract
Congress or journal article abstract